BBIO logo

BridgeBio Pharma (BBIO) EBIT

Annual EBIT

-$442.90 M
+$129.06 M+22.56%

December 31, 2024

Summary

Performance

1-Year Change

+22.56%

3-Year Change

+17.93%

5-Year Change

-58.28%

15-Year Change

-910.76%

BBIO EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

3.12%
BBIO annual earnings before interest & taxes is higher than 3.12% of companies in Healthcare sector

High & Low

All-time High

-$43.82 M

3-Year Low

-$571.96 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
BBIO previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
BBIO next annual earnings announcement has not yet been scheduled

OtherBBIOprofitabilitymetrics:

Annual Revenue

$221.90 M
BBIO annual revenue is $221.90 million

Annual Net Income

-$535.76 M
BBIO annual net profit is -$535.76 million

Annual EBITDA

-$436.83 M
BBIO annual EBITDA is -$436.83 million

Annual EPS

-$2.88
BBIO annual earnings per share is -$2.88

Quarterly EBIT

-$236.41 M
-$95.22 M-67.44%

December 31, 2024

Summary

Performance

3-Month Change

-67.44%

1-Year Change

-67.44%

3-Year Change

-67.44%

5-Year Change

-67.44%

BBIO Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

1.01%
BBIO quarterly earnings before interest & taxes is higher than 1.01% of companies in Healthcare sector

High & Low

All-time High

$17.72 M
BBIO quarterly earnings before interest & taxes is currently -1434.17% below its historical high of $17.72 million

3-Year Low

-$236.41 M
BBIO quarterly earnings before interest & taxes is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
BBIO previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
BBIO next earnings announcement is scheduled for May 2, 2025

OtherBBIOprofitabilitymetrics:

Quarterly Revenue

$5.88 M
BBIO quarterly revenue is $5.88 million

Quarterly Net Income

-$265.05 M
BBIO quarterly net profit is -$265.05 million

Quarterly EBITDA

-$235.05 M
BBIO quarterly EBITDA is -$235.05 million

Quarterly EPS

-$1.40
BBIO quarterly earnings per share is -$1.40

TTM EBIT

-$442.90 M
-$86.36 M-24.22%

December 31, 2024

Summary

Performance

3-Month Change

-24.22%

1-Year Change

-24.22%

3-Year Change

-24.22%

5-Year Change

-24.22%

BBIO TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

2.78%
BBIO TTM earnings before interest & taxes is higher than 2.78% of companies in Healthcare sector

High & Low

All-time High

-$42.42 M

3-Year Low

-$571.96 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
BBIO previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
BBIO next earnings announcement is scheduled for May 2, 2025

OtherBBIOprofitabilitymetrics:

TTM Revenue

$221.90 M
BBIO TTM revenue is $221.90 million

TTM Net Income

-$535.76 M
BBIO TTM net profit is -$535.76 million

TTM EBITDA

-$436.83 M
BBIO TTM EBITDA is -$436.83 million

TTM EPS

-$2.85
BBIO TTM earnings per share is -$2.85

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

-$442.90 M
BBIO annual earnings before interest & taxes is -$442.90 million

Annual Revenue

$221.90 M
BBIO annual revenue is $221.90 million

Annual Cost Of Goods Sold

$3.88 M
BBIO annual cost of goods sold is $3.88 million

Annual Operating Expenses

$795.39 M
BBIO annual total operating expenses is $795.39 million

BBIO EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+22.6%-67.4%-24.2%
3 y3 years+17.9%-67.4%-24.2%
5 y5 years-58.3%-67.4%-24.2%

BBIO EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-9.6%+22.6%-1434.2%at low-28.1%+22.6%
5 y5-year-58.3%+22.6%-1434.2%at low-58.3%+22.6%
alltimeall time-910.8%+22.6%-1434.2%at low-944.0%+22.6%

BridgeBio Pharma EBIT History

DateAnnualQuarterlyTTM
Dec 2024
-$442.90 M(-22.6%)
-$236.41 M(+67.4%)
-$442.90 M(+24.2%)
Sep 2024
-
-$141.19 M(+168.4%)
-$356.55 M(-4.8%)
Jun 2024
-
-$52.61 M(+314.6%)
-$374.54 M(-18.9%)
Mar 2024
-
-$12.69 M(-91.5%)
-$462.04 M(-19.2%)
Dec 2023
-$571.96 M(+41.5%)
-$150.06 M(-5.7%)
-$571.96 M(+5.4%)
Sep 2023
-
-$159.18 M(+13.6%)
-$542.48 M(+7.7%)
Jun 2023
-
-$140.11 M(+14.3%)
-$503.67 M(+45.6%)
Mar 2023
-
-$122.61 M(+1.7%)
-$345.84 M(-14.4%)
Dec 2022
-$404.21 M(-25.1%)
-$120.58 M(+0.2%)
-$404.21 M(-3.9%)
Sep 2022
-
-$120.37 M(-779.3%)
-$420.78 M(-6.6%)
Jun 2022
-
$17.72 M(-109.8%)
-$450.36 M(-19.5%)
Mar 2022
-
-$180.99 M(+32.0%)
-$559.32 M(+3.6%)
Dec 2021
-$539.68 M
-$137.15 M(-8.5%)
-$539.68 M(+2.5%)
Sep 2021
-
-$149.95 M(+64.4%)
-$526.59 M(+6.2%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$91.23 M(-43.5%)
-$495.88 M(-6.5%)
Mar 2021
-
-$161.34 M(+30.1%)
-$530.11 M(+13.1%)
Dec 2020
-$468.83 M(+67.5%)
-$124.06 M(+4.0%)
-$468.83 M(+10.1%)
Sep 2020
-
-$119.24 M(-5.0%)
-$425.88 M(+16.6%)
Jun 2020
-
-$125.46 M(+25.4%)
-$365.19 M(+17.0%)
Mar 2020
-
-$100.07 M(+23.4%)
-$312.13 M(+11.5%)
Dec 2019
-$279.82 M(+67.7%)
-$81.11 M(+38.5%)
-$279.82 M(+13.4%)
Sep 2019
-
-$58.55 M(-19.1%)
-$246.77 M(+7.7%)
Jun 2019
-
-$72.39 M(+6.8%)
-$229.14 M(+19.2%)
Mar 2019
-
-$67.77 M(+41.0%)
-$192.25 M(+15.2%)
Dec 2018
-$166.90 M(+280.9%)
-$48.06 M(+17.4%)
-$166.90 M(+40.4%)
Sep 2018
-
-$40.92 M(+15.3%)
-$118.84 M(+52.5%)
Jun 2018
-
-$35.50 M(-16.3%)
-$77.92 M(+83.7%)
Mar 2018
-
-$42.42 M
-$42.42 M
Dec 2017
-$43.82 M
-
-

FAQ

  • What is BridgeBio Pharma annual earnings before interest & taxes?
  • What is the all time high annual EBIT for BridgeBio Pharma?
  • What is BridgeBio Pharma annual EBIT year-on-year change?
  • What is BridgeBio Pharma quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for BridgeBio Pharma?
  • What is BridgeBio Pharma quarterly EBIT year-on-year change?
  • What is BridgeBio Pharma TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for BridgeBio Pharma?
  • What is BridgeBio Pharma TTM EBIT year-on-year change?

What is BridgeBio Pharma annual earnings before interest & taxes?

The current annual EBIT of BBIO is -$442.90 M

What is the all time high annual EBIT for BridgeBio Pharma?

BridgeBio Pharma all-time high annual earnings before interest & taxes is -$43.82 M

What is BridgeBio Pharma annual EBIT year-on-year change?

Over the past year, BBIO annual earnings before interest & taxes has changed by +$129.06 M (+22.56%)

What is BridgeBio Pharma quarterly earnings before interest & taxes?

The current quarterly EBIT of BBIO is -$236.41 M

What is the all time high quarterly EBIT for BridgeBio Pharma?

BridgeBio Pharma all-time high quarterly earnings before interest & taxes is $17.72 M

What is BridgeBio Pharma quarterly EBIT year-on-year change?

Over the past year, BBIO quarterly earnings before interest & taxes has changed by -$95.22 M (-67.44%)

What is BridgeBio Pharma TTM earnings before interest & taxes?

The current TTM EBIT of BBIO is -$442.90 M

What is the all time high TTM EBIT for BridgeBio Pharma?

BridgeBio Pharma all-time high TTM earnings before interest & taxes is -$42.42 M

What is BridgeBio Pharma TTM EBIT year-on-year change?

Over the past year, BBIO TTM earnings before interest & taxes has changed by -$86.36 M (-24.22%)